The digest for tonight focuses on a retail crowning of a trillion dollars, a geopolitical truce that is fragile, the fall from grace of a pharmaceutical darling, and the brutal reminder by crypto about how liquidity rules everything.
Walmart is transforming, India is experimenting with leverage, but it is a risky move. Novo Nordisk’s blunder exposes the execution risks, and Bitcoin is trading more like high beta assets than digital gold.
There are many fine prints that still have to be read.
Walmart’s market capitalization reaches $1 Trillion
Walmart has become the first retailer in history to reach a market capitalization of $1 trillion. The company reached the milestone after the stock price surged above $126 per share on Tuesday.
This milestone highlights a radical transformation of a discount retailer into a technology-powered giant.
Advertising revenue soared by 53% in the last quarter to offset thin margins at brick-and mortar stores.
John Furner, the new CEO, inherits an organization that is booming. Stocks rose 24% in 2018, and 11% by 2026, destroying S&P500.
Walmart has a secret weapon in its arsenal. It uses physical stores to deliver goods, which is better than Amazon’s delivery model.
India-US trade deal brings relief
Trump has lowered India’s duty rate to just 18% from the previous 50%. This is a huge relief. However, details are still unclear.
Modi has agreed to buy American oil instead of Russian and to commit to buying $500 billion worth of US goods. India’s EU mega deal, dubbed as “the mother of all deals,” is the real catalyst.
Modi was able to use the deal as leverage and not out of desperation, allowing him to bargain from a position of strength.
Details are still hazy. Modi will he stop Russian crude imports or only trim them? It’s not clear when this will happen.
Analysts point out that 18% is still six times more than the 2024 rate, which will hit small businesses in the US. India’s stock exchange crashed in 2018 due to tariff concerns. This deal gives breathing space but does not erase the geopolitical divides.
Washington wanted India to pivot its oil production in order to put pressure on Putin over Ukraine. Modi has political cover, but it is still in the works.
The Novo slide on weak outlook for 2026
Novo Nordisk has dropped a bombshell. 2026 sales are expected to plummet 5-13%. This sent shares in a free fall of 15% on Tuesday.
Pharma giant pointed to brutal US price reductions under Trump’s Most Favored Nation agreement, as well as patent cliffs that killed exclusivity in Canada, Brazil and China.
Eli Lilly’s Mounjaro has eaten their lunch, as it is better and gains market share quicker. Compounding pharmacies are undercutting Wegovy by half.
Mike Doustdar, the new CEO of Lilly Pharmaceuticals is banking on CagriSema and Wegovy (the oral combo drug), to stop bleeding. But that would be a very long shot compared with Lilly’s momentum.
Novo is pointing to double-digit pain. The analysts had expected only a 2% drop.
Last year, the stock market dropped by 46%. Investor confidence has been shattered. Novo has failed too often in its execution. The narrative of a comeback is entirely dependent on this.
Bitcoin drops below $74,000
Bitcoin fell below $74,000 in Tuesday’s trading, marking its lowest level for nine months and a 40% drop from the $126,000 high.
It’s not Iran, but macro-collapse: Fed insecurity after new leadership, rising real yields, dollar strength, and outflows from Bitcoin ETFs, which signal institutional panic.
When liquidity disappears, geopolitical concerns are less important. Liquidations of derivatives cascaded over the weekend, wiping out $5 billion worth of open positions.
The tensions with Iran actually caused oil to crash earlier in January, when Trump threatened to strike. However, higher crude prices crushed safe-haven demands by destroying real returns.
Bitcoin has flipped from a geopolitical hedge asset to a leveraged risk-asset.
It is important to maintain support at $74,000, as if it were breached the bears would have a new goal of $68,000.
Crypto’s downwind is accelerating until the Fed announces rate reductions or stabilization of liquidations.
The post Evening Digest: Walmart’s $1T, Novo’s weak outlook and Bitcoin’s slip below $74K appeared first at ICD
